These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6274454)

  • 1. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
    Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
    Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E rosettes in the uranium miners with lung cancer.
    Kudrna K; Andrlíková J; Smíd A; Stipl Z
    Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of antibody synthesis and expression of T-cell membrane markers by serum factors of patients with small cell carcinoma of the lung.
    Manke HG; Aulenbacher P; Rüster S; Drings P
    Anticancer Res; 1986; 6(4):869-73. PubMed ID: 3019227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subpopulation in primary lung cancer.
    Alsabti EA; Safo MH; Shaheen A
    Oncology; 1979; 36(4):176-9. PubMed ID: 224357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological status in small cell and squamous cell lung cancer].
    Janicka G; Przylipiak M; Chyczewska E; Kowal E
    Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 8. Alveolar cell carcinoma-like antigen and antibodies in patients with alveolar cell carcinoma and other cancers.
    Mohr AJ; Nordquist RE; Rhoades ER; Coalson RE; Coalson JJ
    Cancer Res; 1974 Aug; 34(8):1904-7. PubMed ID: 4366936
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
    Takita H; Brugarolas A
    J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment].
    Janicka G; Chyczewska E; Przylipiak M; Kowal E
    Pol Tyg Lek; 1985 Aug; 40(34):963-6. PubMed ID: 2999734
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibodies specific for two different histological types of human lung carcinoma.
    Saji S; Zylstra S; Schepart BS; Ghosh SK; Jou YH; Takita H; Bankert RB
    Hybridoma; 1984; 3(2):119-29. PubMed ID: 6090307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated immunoglobulins in pulmonary carcinoma.
    Gerstl B; Eng LF; Bigbee JW
    Cancer Res; 1977 Dec; 37(12):4449-55. PubMed ID: 200349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
    Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
    Zółtowska A; Skokowski J; Mlekodaj S; Boj E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor-cell activity.
    Han T; Takita H
    Cancer; 1979 Dec; 44(6):2090-8. PubMed ID: 228835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tumour-specific antibodies in the regional lymph nodes of patients with lung cancer (author's transl)].
    Matsubara Y; Funatsu T; Hatakenaka R; Kuwabara M; Taki T; Miyamoto Y; Kosaba S; Ninomiya K; Ikeda S
    Prax Klin Pneumol; 1980 Sep; 34(9):524-32. PubMed ID: 6256724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.